Read as much as you want on BostonGlobe.com, anywhere and anytime, for just 99¢.

Mass. Movers

Partners again, Isis and Biogen Idec surge

George Scangos is CEO of Biogen Idec, known for its multiple sclerosis drugs.

Globe File Photo/2013

George Scangos is CEO of Biogen Idec, known for its multiple sclerosis drugs.

Continue reading below

Isis Pharmaceuticals Inc., of Carlsbad, Calif., surged 13.3 percent on news Biogen Idec Inc., based in Weston, will make an upfront payment of $100 million as part of a six-year collaboration to develop drugs for neurological disorders. Isis’ specialty is antisense technology, which can activate genes or silence a genetic mutation to help treat disorders. Biogen Idec gets exclusive rights to the technology, the companies said. Isis is also eligible to receive milestone payments, license fees, and royalty payments. Biogen rose 1.6 percent.

Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com